125 related articles for article (PubMed ID: 1574592)
1. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.
Barton MB; Keane TJ; Gadalla T; Maki E
Radiother Oncol; 1992 Mar; 23(3):137-43. PubMed ID: 1574592
[TBL] [Abstract][Full Text] [Related]
2. Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model.
Terhaard CH; Karim AB; Hoogenraad WJ; Tjho-Heslinga R; Keus RB; Mehta DM; Reichgelt BA; Hordijk GJ
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1207-14. PubMed ID: 2045295
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx.
Colasanto JM; Haffty BG; Wilson LD
Cancer J; 2004; 10(1):61-6. PubMed ID: 15000497
[TBL] [Abstract][Full Text] [Related]
6. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
7. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.
Duncan W; MacDougall RH; Kerr GR; Downing D
Radiother Oncol; 1996 Dec; 41(3):203-7. PubMed ID: 9027934
[TBL] [Abstract][Full Text] [Related]
8. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
11. Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer?
Van den Bogaert W; Van der Leest A; Rijnders A; Delaere P; Thames H; van der Schueren E
Radiother Oncol; 1995 Sep; 36(3):177-82. PubMed ID: 8532903
[TBL] [Abstract][Full Text] [Related]
12. Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.
Jentsch C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Krause M; Zips D; Troost EGC; Löck S; Kotzerke J; Steinbach J; Thames H; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2016 Dec; 121(3):447-452. PubMed ID: 27544820
[TBL] [Abstract][Full Text] [Related]
13. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
Yu E; Shenouda G; Beaudet MP; Black MJ
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
[TBL] [Abstract][Full Text] [Related]
14. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.
Moonen L; vd Voet H; de Nijs R; Horenblas S; Hart AA; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):525-30. PubMed ID: 9806510
[TBL] [Abstract][Full Text] [Related]
15. [Radiation therapy of stage III laryngeal cancer].
Alferov VS; Ogol'tsova ES; Kondrat'eva AP
Med Radiol (Mosk); 1989 Dec; 34(12):36-9. PubMed ID: 2601591
[TBL] [Abstract][Full Text] [Related]
16. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck.
Cole CJ; Garden AS; Frankenthaler RA; Reece GP; Morrison WH; Ang KK; Peters LJ
Cancer; 1995 May; 75(9):2356-60. PubMed ID: 7712448
[TBL] [Abstract][Full Text] [Related]
18. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
19. Early-stage glottic cancer: importance of dose fractionation in radiation therapy.
Kim RY; Marks ME; Salter MM
Radiology; 1992 Jan; 182(1):273-5. PubMed ID: 1727295
[TBL] [Abstract][Full Text] [Related]
20. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
